DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, Morgan Stanley Analyst Says
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Morgan Stanley from $75.00 to $82.00 in a report published on Friday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical device company’s stock. Other research analysts also recently issued research reports about the stock. Canaccord Genuity Group lifted their price […]
DexCom (NASDAQ:DXCM – Free Report) had its price target lifted by Morgan Stanley from $75.00 to $82.00 in a report published on Friday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the medical device company’s stock. Other research analysts also recently issued research reports about the stock. Canaccord Genuity Group lifted their price […]
